In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they intend to reclassify cannabis to be a Routine III drug. This rescheduling will understand that cannabis has legitimate medical needs and will help open the doorway to study on other probable cure utilizes. Cannabis-de